Clinical value of ultradeep HIV-1 genotyping and tropism testing in late presenters with advanced disease.

Abstract

OBJECTIVE This article aims to investigate if the detection of preexisting drug-resistant minority variant (DRMV) and/or X4 HIV-1 variants could improve the efficacy of first-line combined antiretroviral therapy (ART) in late presenters. DESIGN Post-hoc, combined analysis of two open-label, prospective, randomized clinical trials comparing first-line ART… (More)
DOI: 10.1097/QAD.0000000000000748

Topics

Cite this paper

@article{Casadell2015ClinicalVO, title={Clinical value of ultradeep HIV-1 genotyping and tropism testing in late presenters with advanced disease.}, author={Maria Casadell{\`a} and Christian Manzardo and Marc Noguera-Julian and Elena Ferrer and Pere Domingo and Susana P{\'e}rez-{\'A}lvarez and Daniel Podzamczer and Montserrat Plana and Bonaventura Clotet and Jose M. Gatell and Jos{\'e} Mir{\'o} and Roger Paredes}, journal={AIDS}, year={2015}, volume={29 12}, pages={1493-504} }